Brief: Tandem Diabetes Care, Dexcom Entered Amended & Restated Development Agreement To Original Development Agreement, Dated Nov 20, 2020
18/06/2024 22:07
June 18 (Reuters) - Dexcom Inc DXCM.O :
* TANDEM DIABETES CARE- ON MAY 22, CO, DEXCOM ENTERED
AMENDED &
RESTATED DEVELOPMENT AGREEMENT TO ORIGINAL DEVELOPMENT
AGREEMENT, DATED NOV 20, 2020
* TANDEM DIABETES CARE - AGREEMENT INCORPORATES INTEGRATION
OF
CO'S SIGI INSULIN PUMP WITH DEXCOM’S G7 CGM DEVICE, EXTENDS TERM
FOR PERIOD OF 5 YEARS
Source text for Eikon: ID:n0001438133-24-000158
Further company coverage: DXCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary